Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor
Anthrax toxin is the major virulence factor produced by Bacillus anthracis. Protective antigen (PA) is the key component of the toxin and has been confirmed as the main target for the development of toxin inhibitors. The inhibition of the binding of PA to its receptor, capillary morphogenesis protei...
Main Authors: | Liangliang Li, Qiang Guo, Ju Liu, Jun Zhang, Ying Yin, Dayong Dong, Ling Fu, Junjie Xu, Wei Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-01-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/8/1/28 |
Similar Items
-
Anthrax Toxin Characterization
by: Jiří Patočka, et al.
Published: (2002-01-01) -
Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination
by: Christopher K. Cote, et al.
Published: (2015-08-01) -
Laboratory diagnostic methods and reported outbreaks of anthrax in Ethiopia
by: Abebe Olani, et al.
Published: (2020-04-01) -
Alternative pre-approved and novel therapies for the treatment of anthrax
by: Breanne M. Head, et al.
Published: (2016-11-01) -
Cutaneous Anthrax Patients: Evaluation of Four Family Members
by: Kamil Tünay, et al.
Published: (2016-03-01)